Stryker (SYK) Competitors $391.46 +2.00 (+0.51%) Closing price 07/14/2025 03:59 PM EasternExtended Trading$393.26 +1.80 (+0.46%) As of 04:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock SYK vs. CSQ, ISRG, BSX, CAH, COR, DVA, MDT, ZBH, ABT, and BDXShould you be buying Stryker stock or one of its competitors? The main competitors of Stryker include Calamos Strategic Total Return Fund (CSQ), Intuitive Surgical (ISRG), Boston Scientific (BSX), Cardinal Health (CAH), Cencora (COR), DaVita (DVA), Medtronic (MDT), Zimmer Biomet (ZBH), Abbott Laboratories (ABT), and Becton, Dickinson and Company (BDX). Stryker vs. Its Competitors Calamos Strategic Total Return Fund Intuitive Surgical Boston Scientific Cardinal Health Cencora DaVita Medtronic Zimmer Biomet Abbott Laboratories Becton, Dickinson and Company Calamos Strategic Total Return Fund (NASDAQ:CSQ) and Stryker (NYSE:SYK) are related companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, institutional ownership, dividends, valuation, media sentiment, analyst recommendations, earnings and risk. Is CSQ or SYK a better dividend stock? Calamos Strategic Total Return Fund pays an annual dividend of $1.23 per share and has a dividend yield of 6.8%. Stryker pays an annual dividend of $3.36 per share and has a dividend yield of 0.9%. Stryker pays out 45.4% of its earnings in the form of a dividend. Stryker has raised its dividend for 32 consecutive years. Which has stronger earnings & valuation, CSQ or SYK? Stryker has higher revenue and earnings than Calamos Strategic Total Return Fund. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCalamos Strategic Total Return Fund$280.21MN/AN/AN/AN/AStryker$22.60B6.61$2.99B$7.4052.90 Do insiders and institutionals have more ownership in CSQ or SYK? 77.1% of Stryker shares are held by institutional investors. 5.2% of Stryker shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Do analysts rate CSQ or SYK? Stryker has a consensus target price of $428.55, indicating a potential upside of 9.48%. Given Stryker's stronger consensus rating and higher possible upside, analysts clearly believe Stryker is more favorable than Calamos Strategic Total Return Fund.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Calamos Strategic Total Return Fund 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Stryker 0 Sell rating(s) 4 Hold rating(s) 15 Buy rating(s) 0 Strong Buy rating(s) 2.79 Does the media refer more to CSQ or SYK? In the previous week, Stryker had 48 more articles in the media than Calamos Strategic Total Return Fund. MarketBeat recorded 49 mentions for Stryker and 1 mentions for Calamos Strategic Total Return Fund. Calamos Strategic Total Return Fund's average media sentiment score of 1.89 beat Stryker's score of 1.40 indicating that Calamos Strategic Total Return Fund is being referred to more favorably in the media. Company Overall Sentiment Calamos Strategic Total Return Fund Very Positive Stryker Positive Is CSQ or SYK more profitable? Stryker has a net margin of 12.31% compared to Calamos Strategic Total Return Fund's net margin of 0.00%. Stryker's return on equity of 23.74% beat Calamos Strategic Total Return Fund's return on equity.Company Net Margins Return on Equity Return on Assets Calamos Strategic Total Return FundN/A N/A N/A Stryker 12.31%23.74%11.25% SummaryStryker beats Calamos Strategic Total Return Fund on 11 of the 14 factors compared between the two stocks. Get Stryker News Delivered to You Automatically Sign up to receive the latest news and ratings for SYK and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SYK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SYK vs. The Competition Export to ExcelMetricStrykerMED PRODUCTS IndustryMedical SectorNYSE ExchangeMarket Cap$149.41B$10.28B$5.54B$20.67BDividend Yield0.86%2.08%5.01%3.71%P/E Ratio52.9016.9728.7027.86Price / Sales6.6129.88373.3956.13Price / Cash25.8223.5224.7217.92Price / Book7.233.668.254.60Net Income$2.99B$233.40M$3.19B$989.89M7 Day Performance0.46%0.96%3.55%0.43%1 Month Performance3.83%5.76%9.57%5.50%1 Year Performance19.14%-15.43%30.52%9.92% Stryker Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SYKStryker4.4841 of 5 stars$391.46+0.5%$428.55+9.5%+15.3%$149.41B$22.60B52.9053,000Positive NewsCSQCalamos Strategic Total Return FundN/A$18.25-1.0%N/A+5.6%$0.00$280.21M0.00N/APositive NewsISRGIntuitive Surgical4.7226 of 5 stars$533.93-1.9%$588.95+10.3%+16.3%$191.36B$8.35B78.2815,638Positive NewsUpcoming EarningsAnalyst ForecastBSXBoston Scientific4.5826 of 5 stars$103.48-0.8%$116.09+12.2%+34.4%$153.09B$16.75B75.5353,000CAHCardinal Health4.8917 of 5 stars$166.47+0.9%$157.43-5.4%+71.8%$39.73B$226.83B25.9748,900Positive NewsCORCencora4.5277 of 5 stars$299.63+1.1%$306.33+2.2%+33.4%$58.07B$293.96B34.7646,000Positive NewsDVADaVita4.46 of 5 stars$142.21-0.2%$164.50+15.7%+1.3%$10.74B$12.82B14.0976,000Positive NewsMDTMedtronic4.5947 of 5 stars$87.52-1.0%$97.87+11.8%+15.1%$112.25B$33.54B24.1895,000Positive NewsZBHZimmer Biomet4.9474 of 5 stars$92.26-1.5%$111.33+20.7%-13.7%$18.25B$7.68B20.4117,000Positive NewsABTAbbott Laboratories4.9556 of 5 stars$133.04-1.0%$142.61+7.2%+26.7%$231.47B$41.95B17.26114,000Upcoming EarningsBDXBecton, Dickinson and Company4.8451 of 5 stars$172.96-1.8%$219.22+26.7%-22.7%$49.57B$20.18B33.0174,000Positive News Related Companies and Tools Related Companies CSQ Alternatives ISRG Alternatives BSX Alternatives CAH Alternatives COR Alternatives DVA Alternatives MDT Alternatives ZBH Alternatives ABT Alternatives BDX Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:SYK) was last updated on 7/15/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Stryker Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Stryker With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
